Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 3 Obesity 2 Endometrial Hyperplasia 2 Weight Loss 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Opioid-Related Disorders 1 Lymphoma, Follicular 1 Hyperplasia 1 Breast Neoplasms 1

Interventions

salicylhydroxamic acid 1 methylnaltrexone 1 Tirzepatide 1 Psilocybin 1 Medical Marijuana 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Opioid-Related Disorders × Tirzepatide × Clear all

NCT06651177 2026-05-22

TAB

University of Cincinnati

Phase 2 Recruiting

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡